Submissions from 2022
Race, Rituximab, and Relapse in TTP, Camila Masias Castanon
Providing Patients’ Tomorrow’s Care Today: Rapidly Bringing Discovery to the Bedside, Minesh Mehta
Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy, Michael Chuong, Roberto Herrera, Antonio Ucar, Santiago Aparo, Fernando De Zarraga, Domenech Asbun, Javier Jimenez, Horacio Asbun, Govindarajan Narayanan, Sarah Joseph, Rupesh Kotecha, Matthew Hall, Kathryn Mittauer, Diane Alvarez, James McCulloch, Tino Romaguera, Alonso Gutierrez, and Adeel Kaiser
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy, Yazmin Odia, Doured Daghistani, Zuanel Diaz, and Matthew Hall
SerpinB3 drives cancer stem cell survival in glioblastoma, Manmeet Ahluwalia
Clinical Trials Lessons Learned, Minesh Mehta
From Bench to Bedside to Beam: Radiotherapy Advances for Brain Tumors., Minesh Mehta
Colecistectomia Segura, Domenech Asbun
Maximizing Angioplasty Results in Peripheral Interventions, Austin Pourmoussa, Constantino Pena, and Barry Katzen
Maximizing Angioplasty Results in Peripheral Interventions, Austin Pourmoussa, Constantino Pena, and Barry Katzen
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta
Multimodality Approaches to Primary and Secondary Brain Tumors, Minesh Mehta
Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: trial in progress, Rupesh Kotecha, Brian Schiro, Justin Sporrer, Muni Rubens, Haley Appel, Martin Tom, and Minesh Mehta
Pearls and Pitfalls in Conducting Neuro-Oncology Trials: Reflections of Experienced Clinical Trialists, Minesh Mehta
Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data, Tugce Kutuk, Haley Appel, Federico Albrecht, Paul Kaywin, Suyen Ramos, Minesh Mehta, and Rupesh Kotecha
Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer, Rupesh Kotecha
Multi-Institutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma, Tugce Kutuk and Rupesh Kotecha
Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis, Federico Albrecht, Rupesh Kotecha, and Zhenwei Zhang
Hypothetical Generalized Framework for a New Imaging Endpoint of Therapeutic Activity in Early Phase Clinical Trials in Brain Tumors, Manmeet Ahluwalia
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease, Camila Masias Castanon
Prediction of peritoneal soiling in acute appendicitis with simple clinical and laboratory data. Prospective, multicenter, cohort study of 2,645 adult patients nationwide, Nuria Lluis Vinas